Publications

November 4, 2019
Physics World

Research Update: PET imaging sheds light on immunotherapy response. Editorial on ImaginAb’s phase I study results published in J. Nucl. Med.

> Click here to read full article. 

October 4 2019
Journal of Nuclear Medicine

First-in-human imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting.

> Click here to read full article. 

July 26, 2019
Manufacturing Chemist

CEO Ian Wilson wrote a bylined article for the on-line and monthly magazine, Manufacturing Chemist, explaining the potential of ImaginAb’s lead product, 89ZrCD8PET, as a key technology in immuno-oncology clinical trials.

> Click here to read full article.

July 11, 2019
Pharmaphorum

CEO Ian Wilson contributed an article to on-line healthcare publication, Pharmaphorum, about the future of imaging immune responses in real cancer patients to realize the full potential of immunotherapy.

> Click here to read full article.

May 22, 2019
Pharmatechnologist.com

interviewed CEO Ian Wilson about the value of AI and ‘machine learning’ tools in understanding disease activity, specifically in connection with whole-body PET molecular imaging.

> Click here to read full article.